Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

MRUS

MRUS News

Newswire

16:12

Merus N.V.'s VP Controller Sells 8300 Shares at $95.92 Per Share.

06:29

Halper Sadeh Investigates Exact Sciences, Enviri, Merus for Potential Violations of Securities Laws.

00:33

Halozyme Therapeutics' (HALO) Valuation Following New Merus Collaboration and Expanded ENHANZE Platform Prospects

08:31

Merus and Halozyme Collaborate on ENHANZE Technology for Petosemtamab Development

07:05

Merus and Halozyme collaborate on subcutaneous delivery of petosemtamab.

View More

About MRUS

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More